APOLLO THERAPEUTICS
Apollo Therapeutics is a collaborative venture between three UK universities (Imperial College London, University College London, and the University of Cambridge) and three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, and Johnson & Johnson Innovation). It provides committed translational funding and drug discovery expertise for novel therapeutics, sourced from the best British academic research, accelerating them towards the clinic. Apollo’s unique model provides quick, inde... pendent access to the resources to grow innovations and champion the best British academic research to industry. Apollo’s experienced team of industry scientists has a proven track record of therapeutic delivery and works in partnership with academics and industry partners, crafting each bespoke project to optimize the chances of long-term success. Apollo Therapeutics aims to create future therapies by partnering with the UK’s globally leading academic science base and UK-based Pharma industry to have a real impact on patient treatments and outcomes.
APOLLO THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.apollotherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
397.85 M USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Silverback Therapeutics
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.
Current Advisors List
Board_member
2023-09-06
Board_member
2021-06-17
Current Employees Featured
Jamie Heath CFO @ Apollo Therapeutics
CFO
2021-06-01
Dr. Richard Mason CEO @ Apollo Therapeutics
CEO
Richard Butt CSO @ Apollo Therapeutics
CSO
2021-06-01
Arjun Krishnan CBO @ Apollo Therapeutics
CBO
2020-07-01
Dr. Sanjay Aggarwal CMO @ Apollo Therapeutics
CMO
2021-11-01
Founder
Investors List
M&G Plc
M&G Plc investment in Series C - Apollo Therapeutics
Patient Square Capital
Patient Square Capital investment in Series C - Apollo Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series C - Apollo Therapeutics
Patient Square Capital
Patient Square Capital investment in Series C - Apollo Therapeutics
M&G Plc
M&G Plc investment in Series C - Apollo Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series C - Apollo Therapeutics
UCL Technology Fund
UCL Technology Fund investment in Series B - Apollo Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Apollo Therapeutics
Reimagined Ventures
Reimagined Ventures investment in Series B - Apollo Therapeutics
Patient Square Capital
Patient Square Capital investment in Series B - Apollo Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-18 | Apollo Therapeutics Appoints Dr. Sanjay Aggarwal as Chief Medical Officer, Opens U.S. Facility |
Official Site Inspections
http://www.apollotherapeutics.com Semrush global rank: 12.87 M Semrush visits lastest month: 78
- Host name: ec2-18-171-93-28.eu-west-2.compute.amazonaws.com
- IP address: 18.171.93.28
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Apollo Therapeutics"
About Us - Apollo Therapeutics
We have a scalable R&D platform for the evergreen discovery and development of new medicines. This is enabled by an unprecedented level of access to breakthroughs in biology …See details»
Team - Apollo Therapeutics
He joined Apollo in 2016 and served as the organization’s Chief Executive Officer until 2021. Richard spent more than 20 years at Pfizer, holding multiple leadership roles in preclinical and …See details»
Apollo Therapeutics - Crunchbase Company Profile & Funding
Apollo Therapeutics is a collaborative venture between three UK universities (Imperial College London, University College London, and the University of Cambridge) and three global …See details»
Apollo Therapeutics - LinkedIn
Apollo Therapeutics | 6,679 followers on LinkedIn. A transformative idea for transformative medicines | Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust …See details»
Apollo Therapeutics Information - RocketReach
Apollotherapeutics.com; 3 44791775XXXX; 44122389XXXX; 44122389XXXX; Emmanuel Demont Head of Medicinal Chemistry at Apollo Therapeutics Stevenage, GB View. View Similar …See details»
Apollo Therapeutics launches as multinational company, backed …
Jun 17, 2021 A unique collaborative venture to speed development of breakthrough medical discoveries—devised by the University of Cambridge, Imperial College London, and University …See details»
Apollo Therapeutics | Startup Profile and Investments
Apollo Therapeutics is a burgeoning biopharmaceutical company that is rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough …See details»
Apollo Therapeutics - VentureRadar
"Apollo Therapeutics is a dynamic company specializing in drug discovery and development. The company employs a portfolio model managed by a centralized team of experts in biology, …See details»
| One Nucleus
Info@apollotherapeutics.com Longer form - Apollo Therapeutics is a collaborative venture between three world-leading UK universities (Imperial College London, UCL and the University …See details»
Apollo Therapeutics - Portfolio Company Profile, Executives and …
See Apollo Therapeutics's complete profile, including its private equity owner and the number of its executive contacts in our database. Apollo Therapeutics is a portfolio-based …See details»
Strategy - Apollo Therapeutics
We are focused on excellence in science-based decision-making and have built a flat, non-hierarchical organization with a dispassionate, truth-seeking culture to facilitate this. There are …See details»
Apollo Therapeutics - Overview, News & Similar companies
Jan 2, 2024 Apollo Therapeutics is a unique collaboration between three global pharmaceutical companies (AstraZeneca UK Limited, Glaxo Group Limited and Johnson & Johnson …See details»
Apollo Therapeutics - PitchBook
Apollo Therapeutics General Information Description. Operator of a biopharmaceutical company intended to focus on translating fundamental medical research into medicines.See details»
Apollo Therapeutics - Products, Competitors, Financials, …
Apollo Therapeutics is a portfolio biopharmaceutical company that focuses on translating breakthroughs in biology and basic medical research into new medicines across various …See details»
Apollo Therapeutics - Craft
Apollo Therapeutics $145 m in total funding,. See insights on Apollo Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Apollo Therapeutics Company Profile | Management and
Smith@apollotherapeutics.com: Apollo Therapeutics Top Competitors. Company Employees Revenue Top technologies; Artios Pharma. 10: $12.9 M: Saint-Gobain. 24: $1.7 M: Isogenica. …See details»
Apollo Therapeutics to go 'full throttle' with $145M raise after 5 ...
Jun 17, 2021 The brainchild of three top U.K. universities and three pharma giants, Apollo Therapeutics made a splash when it debuted in early 2016. Then, crickets. | The brainchild of …See details»
Apollo Therapeutics Completes $145 Million Financing Led by …
Cambridge, UK, June 17, 2021 – Apollo Therapeutics, a portfolio-based biopharmaceutical company rapidly advancing potentially transformative treatments based on breakthrough …See details»
Apollo Therapeutics secures $226.5 million to translate …
Sep 6, 2023 Apollo Therapeutics, a biopharmaceutical company originally set up by three UK universities (Cambridge, Imperial College London and University College London) and three …See details»